跳转至内容
Merck
CN

401442

Goat Anti-Human IgG, γ-Chain Specific Alkaline Phosphatase Conjugate

liquid, Calbiochem®

登录 查看组织和合同定价。

选择尺寸


关于此项目

NACRES:
NA.46
UNSPSC Code:
12352203
Clone:
polyclonal
Application:
Citations:
6
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Goat Anti-Human IgG, γ-Chain Specific Alkaline Phosphatase Conjugate, liquid, Calbiochem®

biological source

goat

antibody form

affinity isolated antibody

antibody product type

secondary antibodies

clone

polyclonal

form

liquid

contains

≤0.1% sodium azide as preservative

manufacturer/tradename

Calbiochem®

storage condition

do not freeze

isotype

IgG

shipped in

wet ice

storage temp.

2-8°C

Quality Level

Application

Enzyme Immunoassay (1:5000)

Immunoelectrophoresis (see comments)

Disclaimer

Toxicity: Standard Handling (A)

General description

Immunoaffinity purified goat polyclonal antibody conjugated to alkaline phosphatase. Recognizes human IgG γ-chain.
This Goat Anti-Human IgG, γ-Chain Specific Alk-Phos Conjugate is validated for use in Enzyme Immunoassay, Immunoelectrophoresis for the detection of Human IgG, γ-Chain Specific.

Immunogen

Human

Other Notes

Monospecific for human IgG γ-chain as determined by immunoelectrophoresis against normal human serum. p-Nitrophenylphosphate, 1 mg/ml in 10% diethanolamine, pH 9.8, 1 mM MgCl2 at 25°C, was used as substrate for testing immunoenzyme reactivity. Variables associated with assay conditions will dictate the proper working dilution.

Packaging

Please refer to vial label for lot-specific concentration.

Physical form

In 50 mM Tris-HCl, 1 mM MgCl₂, 0.1 mM ZnCl₂, 1% BSA, pH 8.0.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Darren Suryawijaya Ong et al.
Nature communications, 15(1), 6968-6968 (2024-08-14)
The use of pneumococcal conjugate vaccine (PCV) schedules with fewer doses are being considered to reduce costs and improve access, particularly in low- and middle-income countries. While several studies have assessed their immunogenicity, there are limited data on their potential
Aapo Knuutila et al.
Emerging microbes & infections, 12(1), 2204146-2204146 (2023-04-16)
Immunization during pregnancy (IP) against pertussis is recommended in many countries to protect infants. Although maternal antibodies can influence the infants' antibody responses to primary vaccinations, their effect on the development of functional antibodies and B cells remain poorly studied.
Pauline Versteegen et al.
Frontiers in immunology, 13, 864674-864674 (2022-06-10)
Immunogenicity of acellular pertussis (aP) vaccines is conventionally assessed by measuring antibody responses but antibody concentrations wane quickly after vaccination. Memory B cells, however, are critical in sustaining long-term protection and therefore may be an important factor when assessing pertussis
Jordan R Barrett et al.
Frontiers in immunology, 14, 1193079-1193079 (2024-02-01)
We have previously reported primary endpoints of a clinical trial testing two vaccine platforms for the delivery of Plasmodium vivax malaria DBPRII: viral vectors (ChAd63, MVA), and protein/adjuvant (PvDBPII with 50µg Matrix-M™ adjuvant). Delayed boosting was necessitated due to trial
Malick M Gibani et al.
Nature medicine, 25(7), 1082-1088 (2019-07-05)
Salmonella Typhi is a human host-restricted pathogen that is responsible for typhoid fever in approximately 10.9 million people annually1. The typhoid toxin is postulated to have a central role in disease pathogenesis, the establishment of chronic infection and human host

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持